Professor, Urology, Rush Medical College of Rush Univ
Urology
Dr. Charles F. McKiel Jr., MD
|
|
Give Review
Charles McKiel is an expert in the field of Urology. He researched medicine at Loyola University Chicago Stritch School of Medicine. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Charles McKiel is a published doctor as well. He has 41 publications published. The latest was: Renal medullary carcinoma in patients with sickle cell trait. He is registered with Medicare.
Publications
- GENITO-Urinary TUBERCULOSIS.
- Changes in radical Prostatectomy and radiation therapy rates for African Americans and whites.
- Renal medullary carcinoma in patients with sickle cell trait.
- TransUrethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study.
- Percutaneous cryoablation of the Prostate: preliminary results after 95 procedures.
- What is the best test to detect prostate Cancer?
- The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the Prostate.
- Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate Cancer.
- A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory Prostate ...
- Treatment of newly diagnosed metastatic prostate Cancer patients with chemotherapy agents in combination with hormones versus hormones alone.
- Gross Hematuria and abdominal aortic aneurysm.
- Endometriosis of the Bladder: case report.
- Marshall-Marchetti procedure: modification.
- Renal artery aneurysms: a report of 16 cases.
- Carcinoma of the urachus: Report of two cases and review of the literature.
- Surgery of Testicular tumors.
- The effect of low-dose cyclophosphamide and immunologic exposure upon growth of established Dunning R-3327-G subline rat Prostate adenocarcinomas.
- Re: In vitro characterization of Mat LyLu: a Dunning rat Prostate adenocarcinoma tumor subline.
- The effect of hormone therapy on peripheral blood leukocytic subset distribution in stage D prostatic Cancer patients.
- Immunobiology of the Dunning R-3327 rat Prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins.
- Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants.
- Administration of recombinant tumor necrosis factor to rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinoma.
- Role of transurethral resection of the Prostate in hematogenously disseminated metastasis.
- New transurethral system for interstitial radiation of prostate Cancer.
- Combination therapy using polyamine synthesis inhibitor alpha-difluoromethylornithine and adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic...
- Effect of BCG upon functional and phenotypic immune markers in rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinoma.
- Effect of cyclophosphamide on leukocytic subset distributions in rats carrying the Dunning R3327-MAT-LyLu prostatic adenocarcinoma.
- Leukocytic subset distributions of spleen cells obtained from rats bearing variants of the Dunning prostatic adenocarcinoma.
- Application of immunohistologic staining to develop a malignant index to aid in distinguishing benign from malignant prostatic tissue.
- Review of acid phosphatase in the diagnosis and prognosis of prostatic Cancers.
- GM-CSF restoration of a differentiated (growth factor-regulated) phenotype in an anaplastic tumor.
- Tumor infiltrating lymphocytes: the effect of bacillus Calmette Guerin on helper/suppressor-T cell ratios of treated and untreated tumors.
- Characterization of cellular infiltrates in the rat urinary Bladder following BCG and thiotepa intravesical therapy.
- Acquired immunodeficiency syndrome presenting as Testicular lymphoma.
- Coordinate loss of growth regulatory factors following castration of rats carrying the Dunning R3327 G prostatic tumor.
- Responsiveness of lymphocytes to soluble exTracts of prostatic tumors and abrogation by serum-blocking factor(s).
- Prostate carcinoma: immunostaging and adjuvant immunotherapy with BCG.
- The carcinoembryonic antigen test in urologic Cancer.
- Cellular immunity in Bladder cancer patients.
- Case profile: giant ileal conduit stone.
Schools
Loyola University of Chicago Stritch School of Medicine
St LukeS Hospital
Presby St Lukes Hospital
Procedures Preformed
- AdRenalectomy
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Incontinence Sling Procedure
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- View All
Conditions Treated
- Bladder Cancer
- Bladder Stones
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Rush University Medical Center -
Loyola University Chicago Stritch School of Medicine
Hospital
-
Rush University Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Courtney M. Hollowell, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Lev Elterman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Gomez, MD |
|
|
Dr. Norm D. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendy Olson Padilla, MD |
|
|
Dr. John J. Cudecki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William W. Lin, MD |
|
|
Dr. April A. Szafran, MD |
|
|
Dr. Neha Malhotra, MD |
|
|
Dr. Vignesh T. Packiam, MD
This Doctor is OpenDoctor Recommended.
|